Free AIDS Drugs

Cardinal Tarcisio Bertone, the Vatican secretary of state, called for free universal access to AIDS drugs and therapy and insisted this begin by giving antiretroviral drugs to H.I.V.-positive pregnant women. “We cannot continue to tolerate the deaths of so many mothers; we cannot think of thousands of babies as a lost generation,” said Cardinal Bertone on June 22, speaking at a conference in Rome on preventing mother-to-child transmission of H.I.V., sponsored by the lay Community of Sant’Egidio. The community runs Dream, a free AIDS prevention and treatment project operating in 10 African nations. Cardinal Bertone said the results of Dream and research by the World Health Organization “confirm that universal access to care is achievable, scientifically proven and economically feasible.” According to Sant’Egidio, 60 percent of those living with H.I.V.-AIDS in sub-Saharan Africa in 2010 were women, and AIDS was the leading cause of death in women of childbearing age.

Comments are automatically closed two weeks after an article's initial publication. See our comments policy for more.

Advertisement
Advertisement

Don't miss the best from America

Sign up for our Newsletter to get the Jesuit perspective on news, faith and culture.

The latest from america

Jesus “is here in Lima, or wherever you are living, in the routine of your daily life and work.”
Gerard O’ConnellJanuary 21, 2018
People and cheered Pope Francis everywhere he went on this last day of his visit.
Gerard O’ConnellJanuary 21, 2018
A boy presents a hat to Pope Francis upon his arrival at the international airport in Trujillo, Peru, Jan. 20. (CNS photo/Paul Haring)
“Just as the apostles faced the storm on the sea, you had to face the brunt of ‘El Niño costero.’”
Gerard O’ConnellJanuary 20, 2018
Pope Francis greets the crowd before celebrating Mass at the Maquehue Airport near Temuco, Chile, Jan. 17. (CNS photo/Paul Haring)
“Pope Francis’ statements...were a source of great pain for survivors of sexual abuse,” Cardinal O’Malley said in a statement released Jan. 20.
Michael J. O’LoughlinJanuary 20, 2018